A new ai model has been developed to improve the prediction of cancer immunotherapy success. The model aims to identify who will respond to cancer immunotherapy drugs, although the specifics of its application and the types of cancer it targets are not clear. Research in the field of ai and cancer treatment is ongoing, with various studies exploring its use in predicting treatment responses and outcomes for different types of cancer.